Next Article in Journal
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Comparative Proteome Analysis of the Response of Ramie under Drought Stress
Next Article in Special Issue
Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches
Previous Article in Journal
An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate
Previous Article in Special Issue
Antimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci
Article

Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites

1
Chemistry Department, College of Natural and Applied Sciences, University of Dar es Salaam, P.O. Box 35061, 14115 Dar es Salaam, Tanzania
2
National Institute for Medical Research (NIMR), P.O. Box 9653, 14115 Dar es Salaam, Tanzania
*
Author to whom correspondence should be addressed.
Academic Editor: Már Másson
Int. J. Mol. Sci. 2016, 17(10), 1559; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17101559
Received: 18 July 2016 / Revised: 23 August 2016 / Accepted: 30 August 2016 / Published: 27 September 2016
(This article belongs to the Special Issue Drug Delivery and Antimicrobial Agents)
Chitosan (CS, molecular weight 20.2 kDa, degree of deacylation (DD) 73.31%) was successfully obtained by deacetylation of chitin extracted from shrimp (Litopenaeus vannamei) shell wastes. The encapsulation of the bioactive natural product, panchovillin (PANV), isolated from Erythrina schliebenii, on a chitosan-tripolyphosphate (CS/TPP) nano-framework was achieved by ionotropic gelation. Characterization of pure CS, CS/TPP and PANV-CS/TPP nanocomposites was performed by FTIR, SEM and XRD. The molecular weight of chitosan and the thermal stability of the materials were determined by MALDI-TOF-MS and simultaneous thermal analyzer (STA)/DTG, respectively. The respective encapsulation efficiency and loading capacity of the PANV were found to be 70% and 0.36%. The in vitro release studies showed an initial burst of 42% of PANV in the first six hours. This was followed by a slow and sustained release up to 72 h. The in vivo antimycobacterial activities of both PANV and PANV-CS/TPP nanocomposite against Mycobacterium indicus pranii (MIP) using Galleria mellonella larvae as an in vivo infection model are reported in this paper. View Full-Text
Keywords: panchovillin; chitosan; nanocomposites; antimycobacterial; Galleria mellonella panchovillin; chitosan; nanocomposites; antimycobacterial; Galleria mellonella
Show Figures

Graphical abstract

MDPI and ACS Style

Rwegasila, E.; Mubofu, E.B.; Nyandoro, S.S.; Erasto, P.; Munissi, J.J.E. Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites. Int. J. Mol. Sci. 2016, 17, 1559. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17101559

AMA Style

Rwegasila E, Mubofu EB, Nyandoro SS, Erasto P, Munissi JJE. Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites. International Journal of Molecular Sciences. 2016; 17(10):1559. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17101559

Chicago/Turabian Style

Rwegasila, Edward, Egid B. Mubofu, Stephen S. Nyandoro, Paul Erasto, and Joan J.E. Munissi 2016. "Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites" International Journal of Molecular Sciences 17, no. 10: 1559. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17101559

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop